Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 4

VERADIGM INC

MDRXOTCEQUITYCurrent

SEC Filing

Filed Jun 3, 2026Accepted Jun 3, 2026, 4:30 PM EDTCIK 1124804Accession 0001193125-26-255558
Share

Company context

Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

Current securities

Recent company filings

  1. Regulation FD DisclosureSep 15, 2026
  2. Other EventsSep 8, 2026
  3. Regulation FD DisclosureSep 8, 2026
  4. Regulation FD DisclosureAug 17, 2026
  5. NT 10-Q filingAug 11, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗